Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y003145 | — |
No symptomatic adverse events; the patient received a third dose of PEDVAXHIB at 6 months of age.; This spontaneous report was received from a nurse and refers to a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not reported. On 06-Jan-2025, the patient was vaccinated with a third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) injection (lot #Y003145 has been verified to be a valid lot number, expiration date: 12-Sep-2026; 0.5ml/ series; route and strenght were not provided) for prophylaxis (inappropriate schedule of product administration). No symptomatic adverse events were reported. This is one of the several reports from the same reporter/facility.